Cargando…
Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development
TGF-β is known to influence tumour progression. Here we report an additional role of Smad3 in the tumour microenvironment regulating cancer progression. Deletion or inhibition of Smad3 in the tumour microenvironment suppresses tumour growth, invasion and metastasis in two syngeneic mouse tumour mode...
Autores principales: | Tang, Patrick Ming-Kuen, Zhou, Shuang, Meng, Xiao-Ming, Wang, Qing-Ming, Li, Chun-Jie, Lian, Guang-Yu, Huang, Xiao-Ru, Tang, Yong-Jiang, Guan, Xin-Yuan, Yan, Bryan Ping-Yen, To, Ka-Fai, Lan, Hui-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343519/ https://www.ncbi.nlm.nih.gov/pubmed/28262747 http://dx.doi.org/10.1038/ncomms14677 |
Ejemplares similares
-
AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice
por: Chung, Jeff Yat-Fai, et al.
Publicado: (2022) -
TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015) -
Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition
por: Tang, Philip Chiu‐Tsun, et al.
Publicado: (2021) -
TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs
por: Tang, Patrick Ming-Kuen, et al.
Publicado: (2017) -
AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF‐β/Smad signalling in hepatocellular carcinoma
por: Chung, Jeff Yat‐Fai, et al.
Publicado: (2021)